Contact Person
    Helen Pettersson

    Senior Project Manager
    Email: hp@mva.org
    Phone: (M) +45 2337 0040
    LinkedIn

    Neutrons for the Life Science Industry

     – How can your R&D benefit from ESS?

    In our region there is a construction going on for the world’s most powerful pulsed neutron source. It is currently being build in Lund, Sweden.

    The European Spallation Source (ESS) is a multi-disciplinary research facility enabling new opportunities for researchers across the spectrum of scientific discovery, including life sciences, energy, environmental technology, cultural heritage and fundamental physics. 

    To make sure that the Life Science Industry takes advantage of this opportunity, Medicon Valley Alliance with cooperation of the European Spallation Source invites you to take part in this seminar.

    Participants will have the opportunity to learn what big science facilities like ESS can offer to industry and how companies can enhance their research capacity to carry out experiments at these facilities. The event will also address strategic market players, which have their own research infrastructure, as human capital transfers and knowledge transfers are crucial for further development within individual branches of industry.

    Date: 7th March 2017
    Time: 12:30 – 17:00
    Venue: Auditorium, Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen

    SIGN UP

    Programme

    12:30 Registration & sandwich lunch
    13:00

    Welcome
    Petter Hartman, CEO Medicon Valley Alliance

    13:10

    The European Spallation Source
    John Womersley, Director-general ESS

    13:30

    Industrial Use of ESS
    Andreas Schreyer, Director for Science, ESS

    13:50 The benefits of neutrons for Life Sciences

    Andreas Bøgglid, Aarhus University

    14:10 LINX – the Danish Industry Portal

    Jimmy Binderup, Director LINX Association

    14:25 Coffee break
    14:45

    Vinnova’s strategy to support industrial usage of ESS
    Peter Eriksson, Head of Operational Development Department Vinnova

    15:00 Case Studies

    Gerd Schluckebier, Director Protein Structure, Novo Nordisk
    Martin Alm, Head of Polymers, Biomodics

    15:20

    Structured Discussion

    Moderator
    Allen Weeks, Head of Communications and External Relations, ESS

    Participants
    Marc Thiry, Horizon 2020 project “SINE 2020”
    Björn Walse, CEO, SARomics Biostructures AB
    Anna Stenstam, CEO, Colloidal Resource AB

    16:00 Reception

     

     

    Organized by In Collaboration with  

     

    cld15suwkaauqtu

     

    ESS_Logo_Frugal_Blue_cmyk